GILD
GILD
Gilead Sciences, Inc.
$133.10
+$0.05 (+0.03%)
Mkt Cap: $165.25B
Home / GILD / Financial Statements

Gilead Sciences, Inc. (GILD) Financial Statements

Export as clean Markdown. Drag & drop into ChatGPT, Claude, or Gemini.

Metric TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue
$29.73B
$29.44B ↑2.4%
$28.75B ↑6.0%
$27.12B ↓0.6%
$27.28B ↓0.1%
$27.30B
Cost of Revenue
$6.14B
$6.23B ↓0.3%
$6.25B ↓3.8%
$6.50B ↑14.9%
$5.66B ↓14.3%
$6.60B
Gross Profit
$23.59B
$23.21B ↑3.1%
$22.50B ↑9.1%
$20.62B ↓4.7%
$21.62B ↑4.4%
$20.70B
R&D Expenses
$5.79B
$5.80B ↓1.8%
$5.91B ↑3.3%
$5.72B ↑14.9%
$4.98B ↑8.2%
$4.60B
SG&A Expenses
$5.90B
$5.71B ↓6.3%
$6.09B ↑0.0%
$6.09B ↑7.4%
$5.67B ↑8.1%
$5.25B
Operating Income
$11.38B
$11.70B ↑604.0%
$1.66B ↓78.1%
$7.61B ↑3.8%
$7.33B ↓26.1%
$9.92B
Interest Expense
$1.00B
$1.02B ↑4.8%
$977.00M ↑3.5%
$944.00M ↑1.0%
$935.00M ↓6.6%
$1.00B
Income Tax
$1.51B
$1.29B ↑509.5%
$211.00M ↓83.1%
$1.25B ↓0.1%
$1.25B ↓39.9%
$2.08B
Net Income
$9.22B
$8.51B
$480.00M ↓91.5%
$5.67B ↑23.4%
$4.59B ↓26.2%
$6.22B
EBITDA
$13.33B
$13.58B ↑206.3%
$4.43B ↓57.8%
$10.50B ↑18.6%
$8.85B ↓21.9%
$11.33B
EPS
7.34
6.78
0.38 ↓91.6%
4.50 ↑23.6%
3.64 ↓26.2%
4.93
Shares Out (Diluted)
5.02B
1.25B -
1.25B ↓0.2%
1.26B ↓0.3%
1.26B -
1.26B